Covid is going to be endemic like the flu and cold. It's not going to be eradicated, unfortunately, and I don't think we've come to terms with this yet. Now what's our plan exactly? Get vaccinated every 6 - 12 months indefinitely and always wear masks? What's our goal and what's our new normal?
Take Vitamin D/C/Zinc/Niacin and build up natural immunity?
Relatively early in 2020, some grocery and pharmacy shelves were completely emptied of Vit C/D/Zinc/Quercetin. When they were restocked, they would sell out again, even with per-customer quotas. This took place even with a complete news blackout on early treatments. As with HCQ/Ivermectin, we have decades of data showing very low risk of adverse effects from these early treatments. So the worst case is that people waste money on placebos. But there are studies showing that early treatment helps some (not all) patients to recover more quickly.
Just as we don't know why some people are injured by vaccines, we don't know why some people are not helped by early intervention with supplements. More studies are need for both, including funding for autopsies of those who die and retroactive genomic sequencing of virus/vaccine/supplement samples collected from the most severely affected cases.
India (origin of Delta) provides comparative data because some areas have rejected Ivermectin while other areas have embraced it. This is a ZH (sorry) article, but it uses data from Johns Hopkins, https://www.zerohedge.com/covid-19/indias-ivermectin-blackou...
> This data shows how Ivermectin knocked their COVID-19 cases and deaths - which we know were Delta Variant - down to almost zero within weeks. A population comparable to the US went from about 35,000 cases and 350 deaths per day to nearly ZERO within weeks of adding Ivermectin to their protocol.
> Let us look at the August 5 numbers from Uttar Pradesh with 2/3 of our population. Uttar Pradesh, using Ivermectin, had a total of 26 new cases and exactly THREE deaths. The US without Ivermectin has precisely 4889 times as many daily cases and 191 times as many deaths as Uttar Pradesh with Ivermectin.
At present, there are billions of dollars of economic incentives for suppression of early treatment, because vaccines are still under EUA that could be questioned by the availability of therapeutics with decades of safety data. If the FDA fully approves one or more vaccines in September 2021, perhaps there will be more economic incentives to perform research and studies of therapeutics.
Merck (original holder of the Ivermectin patent) is developing a new patented therapeutic for early treatment of Covid. Time will tell whether this is a genuinely new treatment or an "evergreen" variant of Ivermectin to obtain patent revenue. Either way, it would mean that at least one Big Pharma company has an economic incentive to promote early therapeutics for Covid, which could provide some balance to the currently polarized treatment landscape.